Management - Recensione dipendente - Dipendente anonimo presso Sanofi

1,0
16 set 2016
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

The focus of the company is to improve patient health and quality of life. The company employs a group of stellar scientists involved in groundbreaking research and all other departments translate the results of the research into a product that will help patients.

Svantaggi

Prior to Sanofi's acquisition of Genzyme Corporation, Genzyme's employees were a "family", a culture that the corporation actively promoted. Employees were inspired and highly motivated to achieve company goals and as such, they were rewarded, not only through salary, but also by stock options. Management was fair, approachable and truly dedicated to helping its employees advance. After Sanofi's acquisition, the "family culture" disappeared. Employees were no longer rewarded with stock options, management was no longer approachable, nor dedicated to helping employees advance. As a result, Sanofi experienced an extremely high attrition in stark contrast to Genzyme's extremely low attrition.

Esplora altre recensioni su Sanofi

5,0
24 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

work life balance, benefits, flexibility

Svantaggi

less competitive salary, less promotion

3,0
1 lug 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Extensive and active employee resource groups, strong leadership development opportunities, clear company mission, gig opportunities that support career development, strong employee support through the ombuds office and compliance help line, and stable company portfolio.

Svantaggi

No work-life balance considerations with hybrid work model, contradictions in company mission compared to policies (i.e., target to reduce carbon emissions with employee commuting to office as one of the top 5 causes but yet still requiring employees to commute to office 3 days a week), some office sites are not conducive to in office productivity (not enough privacy or space), compensation package is not competitive for MA pharmaceutical companies, long-term incentives have almost no value once they are vested, health care benefits require employees to jump through hoops to maximize discounts or qualify for coverage of certain medications, and accountability for department leadership to follow the corporate leadership pillars is inconsistent across departments.

Vedi recensioni per: Utile|Valutazione|Data|Tutto